Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 62.58B 9.32B 8.08B 7.62B 6.91B 12.97B 893B 13.07B 91.03B 35.08B 453B 35.01B 34.24B 1,441B | P/E 2026 * |
47.3x | P/E 2027 * | 35.7x |
|---|---|---|---|---|---|
| Enterprise Value | 57.91B 8.63B 7.47B 7.05B 6.4B 12B 827B 12.09B 84.23B 32.46B 419B 32.4B 31.68B 1,333B | EV / Sales 2026 * |
7.16x | EV / Sales 2027 * | 6.01x |
| Free-Float |
61.13% | Yield 2026 * |
0.76% | Yield 2027 * | 1.02% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 1998-10-06 |
Rui Yang
CEO | Chief Executive Officer | 49 | 2022-01-18 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 9.32B | ||
| +2.02% | -0.96% | +50.69% | +92.40% | 1,015B | ||
| +0.28% | -3.24% | +49.57% | +62.65% | 642B | ||
| +1.81% | +2.07% | +19.89% | +70.38% | 463B | ||
| -0.84% | +2.17% | +37.52% | +37.02% | 353B | ||
| 0.00% | +1.74% | +16.47% | +23.28% | 265B | ||
| -0.38% | +1.72% | +5.83% | +10.42% | 254B | ||
| +1.10% | -12.75% | +38.03% | +45.44% | 206B | ||
| -0.20% | -4.38% | -21.37% | -58.11% | 191B | ||
| +1.87% | -3.04% | +27.81% | +89.26% | 182B | ||
| Average | +0.47% | -3.35% | +24.94% | +41.42% | 396.69B | |
| Weighted average by Cap. | +0.53% | -2.21% | +33.70% | +56.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.2B 1.04B 985M 894M 1.68B 115B 1.69B 11.77B 4.53B 58.58B 4.53B 4.43B 186B | 9.8B 1.46B 1.27B 1.19B 1.08B 2.03B 140B 2.05B 14.26B 5.49B 71B 5.48B 5.36B 226B |
| Net income | 1.41B 210M 182M 172M 156M 293M 20.15B 295M 2.05B 791M 10.22B 790M 772M 32.5B | 1.82B 271M 235M 221M 201M 377M 25.95B 379M 2.64B 1.02B 13.16B 1.02B 994M 41.85B |
| Net Debt | -4.67B -696M -603M -569M -516M -969M -66.72B -976M -6.8B -2.62B -33.85B -2.61B -2.56B -108B | -3.66B -545M -472M -445M -404M -758M -52.19B -763M -5.32B -2.05B -26.48B -2.05B -2B -84.18B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















